Patient outcomes up to 15 years after stroke:Survival, disability, quality of life, cognition and mental health by Crichton, Siobhan Laura et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1136/jnnp-2016-313361
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Crichton, S. L., Bray, B. D., McKevitt, C. J., Rudd, A. G., & Wolfe, C. D. A. (2016). Patient outcomes up to 15
years after stroke: Survival, disability, quality of life, cognition and mental health. Journal of Neurology,
Neurosurgery and Psychiatry, 87(10), 1091-1098. 10.1136/jnnp-2016-313361
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
 
 
 
1 
 
Patient outcomes up to 15 years after stroke: Survival, disability, quality of life, 
cognition and mental health  
Siobhan L Crichton * 1,2, Benjamin D Bray * 3, Christopher McKevitt1,2, Anthony G Rudd1,2, 
Charles DA Wolfe1, 2, 4 
1. Division of Health and Social Care Research, King’s College London, London, UK; 
2. NIHR Biomedical Research Centre, Guy’s & St. Thomas’ NHS Foundation Trust and 
King’s College London, London, UK. 
3. Farr Institute of Health Informatics, University College London, London, UK 
4. National Institute of Health Research Collaboration for Leadership in Applied Health 
Research and Care (CLAHRC) South London, London, UK 
 
*BB and SC are joint first authors.  
Corresponding author:  
Siobhan Crichton 
Division of Health and Social Care Research 
Faculty of Life Sciences & Medicine  
King’s College London 
5th Floor Addison House[1] 
Guy’s Campus 
London SE1 1UL 
Email: Siobhan.crichton@kcl.ac.uk  
Telephone: +4420 7848 6685 
 
 
 
2 
 
ABSTRACT  
Background 
The global epidemiological shift of disease burden towards long term conditions means 
understanding long-term outcomes of cardiovascular disease is increasingly important. More 
people are surviving stroke to experience it's long term consequences, but outcomes in 
people living more >10 years after stroke have not been described in detail.  
Methods 
Data were collected for the population-based South London Stroke Register, with participants 
followed up annually until death.  Outcomes were survival, disability, activity, cognitive 
impairment, quality of life, depression and anxiety.  
Findings 
Of 2625 people having first-ever stroke, 262(21%) survived to 15 years. By 15 years, 61%(95% 
CI 55- 67%)  of the survivors were male, with a median age of stroke onset of 58 years (IQR 
48-66). 87% of the 15 year survivors were living at home and 33.8%(26.2-42.4%) had mild 
disability, 14.3% (9.2-21.4%) moderate disability and 15.0%(9.9-22.3%) severe disability. The 
prevalence of disability increased with time but one in ten of the 15 year survivors had lived 
with moderate-severe disability since their stroke. At 15 years, the prevalence of cognitive 
impairment was 30.0%(19.5-43.1%), depression 39.1%(30.9-47.9%) and anxiety 34.9%(27.0-
43.8%) and survivors reported greater loss of physical than mental quality of life.  
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Conclusions 
One in five people live at least 15 years after a stroke and poor functional, cognitive and 
psychological outcomes affect a substantial proportion of these long term survivors. As the 
global population of individuals with cardiovascular long term conditions grows, research and 
health services will need to increasingly focus on preventing and managing the long term 
consequences of stroke. 
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INTRODUCTION  
Stroke affects an estimated 17 million people each year globally [1], a number projected to 
increase as a result of demographic changes and a greater number of people living to older 
ages where the risk of stroke is greatest. The Global Burden of Disease study has estimated 
that despite falling age-standardised rates of incident stroke, the number of strokes occurring 
worldwide increased by 68% and the number of stroke survivors by 84% between 1990 and 
2010.[1] Due to improvements in acute stroke care such as organised inpatient stroke unit 
based care,[2] a greater proportion of patients are surviving the acute stroke episode.[3] For 
many survivors and their families, this results in living a life affected by the long term 
consequences of stroke, such as physical disability, cognitive impairment,[4]fatigue and 
psychological problems such as depression and anxiety.[5] Stroke is therefore shifting away 
from being a major killer to becoming a long term (chronic) condition with multiple impacts 
on individuals, health systems and society.[1 6]  
Our current knowledge of the long term consequences of stroke is limited by the short follow 
up of most previous studies of stroke outcomes. There are few studies of outcomes 5-10 years 
after stroke [7-9] and previous studies of outcomes more than 10 years after stroke have 
included only small numbers of patients (60 in total from population based registers) and 
described only a small number of outcomes.[7 10-15](summarised in supplementary Table 
A). As a result, there have been very little data available to forecast what will be the 
consequences of the epidemiological shift towards stroke being a long term condition. 
Outcomes data from other cardiovascular conditions such as myocardial infarction are also 
lacking for longer periods of follow up and limited largely to survival rather than other health 
 
 
 
5 
 
outcomes;[16 17] describing the long term outcomes of stroke therefore contributes to a 
broader understanding of the population impact of cardiovascular long term conditions.  
We therefore aimed to estimate the long term outcomes of stroke across multiple domains 
of health (survival, functional, cognitive, quality of life and mental health) up to 15 years after 
stroke, using data from a population based register designed to identify all people with first 
ever stroke in a geographically defined area of London. 
METHODS 
Study Population 
The South London Stroke Register (SLSR) is a prospective population based stroke register set 
up in January 1995, recording all first-ever strokes in patients of all ages for an inner area of 
South London based on 22 electoral wards in Lambeth and Southwark.  
At the time of the 2001 census the SLSR source population consisted of 271817 individuals 
(63% white, 24% black and 9% other ethnic groups). The population rose to 357,308 (56% 
white, 25% black and 18% other ethnic groups) by the time of the 2011 census and is more 
ethnically diverse than the UK as a whole (86% white).  .  
 
Case Ascertainment  
Methods used in data collection have been previously described [18]and are summarised 
below. Standardised criteria were applied to ensure completeness of case ascertainment, 
including multiple overlapping sources of notification [18]. Stroke was defined according to 
World Health Organization criteria [18], and all subarachnoid haemorrhages (ICD-10 code 
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I60.–), intracerebral haemorrhages (I61.–), cerebral infarctions (I63.–), and unspecified 
strokes (I64) were included. Patients admitted to hospitals serving the study area were 
identified by regular reviews of acute wards admitting stroke patients, checks of brain 
imaging, and monthly reviews of bereavement officer and bed manager records. Death 
certificates were checked regularly. Completeness of case ascertainment has been estimated 
at 88% by a multinomial-logit capture-recapture model using the methods described in detail 
elsewhere.[19] Registration of first stroke recurrence was performed in the same way as the 
initial stroke.[20] 
Data Collection 
Trained study nurses and field workers collected the data and a study doctor verified the 
diagnosis of stroke. Participants were examined within 48h of referral to SLSR where possible. 
Participants were assessed at 3 months and annually after stroke. Follow-up data were 
collected using postal or questionnaires administered face to face with patients and/or carers, 
which included a number of validated instruments.. Participants who had left the SLSR area 
were followed up where possible using telephone interviews or postal questionnaires. The 
validated instruments used to measures outcomes included activities of daily living using the 
Barthel Index (BI) ,[21] extended activities of daily living using the Frenchay Activities Index 
(FAI),[22] cognitive impairment using the Abbreviated Mental Test (AMT),[23] anxiety and 
depression using the Hospital Anxiety and Depression Scale (HADS) [24] and health related 
quality of life (HRQOL) using the SF12.[22] 
Cut-off points for defining outcomes were defined a priori. A score on the BI of 0 to 9 was 
used to identify patients with severe (BI < 9) disability, 10-14 for moderate, 15 to 19 for mild 
and 20 to identify those who were independent.[25] The FAI was used to categorise 
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participants with a score <16 categorised as “inactive”, 16-30 as moderately active and 31+ 
as active.[26] 
Participants were defined as cognitively impaired if they had an AMT score < 8.[27] The HADS 
consists of two subscales and each subscale was used to identify cases of anxiety and 
depression (score>7).[28] 
HRQOL was measured using the SF36 in follow-ups to 1stt March 1999, when it was replaced 
with the SF-12. The 12 items of the SF-12 have been adopted from the SF-36 verbatim, and 
summary scores are replicable and reproducible.[29] Therefore, items from the SF-36 
questionnaires in earlier follow-ups were used to derive SF-12 summary scores across all time 
points. The SF12 is summarised using two domains which represent physical and mental 
health.[22] The summary scores range from 0 to 100 and are based on population norms with 
a mean of 50 and a standard deviation of 10.   
Data included were of patients with a first ever stroke between 1st January 1995 and 31st 
December 2003. Information on long term outcomes of surviving participants was extracted 
from the annual follow up to 15 years after stroke. Survival time was defined as time between 
stroke onset and death, using date of death extracted from the national statutory register of 
deaths. For participants still alive on 31st December 2014, survival time was censored and 
defined as time between stroke onset and the end of 2014. Survival free of recurrence was 
defines as time between initial stroke onset and time of second stroke. Patients were 
censored on 31st December 2014 or at the time of death, whichever was soonest, meaning 
not all patients had a full 15 years of follow up..   
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Statistical Analysis 
Kaplan–Meier estimates were used to model survival and to measure the cumulative survival 
and cumulative survival free of recurrence with95% confidence intervals up to 15 years after 
stroke. The characteristics of all participants and those who were alive at 10 and 15 years 
after stroke were summarised as frequency (percentage) or median (inter-quartile range). 
The loss to follow up rate at each time point was calculated as the percentage of participants 
who were alive but missed the interview. Binomial confidence intervals were calculated for 
point prevalence estimates. The characteristics of participants who were alive and followed 
up at each time point were compared to those who were lost to follow up using Chi-squared 
and Mann Whitney U tests. Long term outcomes were summarised as the proportions in each 
of the predefined BI, FAI, AMT and HAD’s categories. A poor outcome was defined as 
moderate-severe disability, inactivity, cognitive impairment, anxiety or depression and the 
number of poor outcomes reported by participants at each time point calculated. All data 
available at each time point were included and participants who were lost to follow up at one 
point remained eligible for inclusion in later follow ups.  
Analysis was conducted using Stata 13MP and R 2.15.1  
Ethics 
All patients or their relatives gave written informed consent to participate in the study, and 
over the study period very few patients have declined to be registered. The design of the 
study was approved by the ethics committees of Guy’s and St Thomas’ NHS Foundation Trust, 
King’s College Hospital Foundation Trust, St George’s University Hospital, National Hospital 
for Nervous Diseases, and Westminster Hospital. 
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RESULTS  
 
Between 1st January 1995 and 31st December 2003, 2626 first ever strokes were recorded. 
The follow up rates among survivors at 10 and 15 years after stroke were 56.7% and 50.8% 
respectively. A full breakdown of the number of participants eligible for each follow-up and 
the numbers completing follow up is available in Figure S1. At 10 years, those who were lost 
to follow up were on average 3·4 years younger than those who were followed up (p=0·001). 
There were no significant differences in the characteristics of participants who were lost to 
follow up in terms of sex (p=0·789 and 0·707), ethnicity (p=0·273 and p=0·273) or stroke type 
(p=0·588 and =0·243) at either time point or in age at 15 years (p=0·128).   
Participants were followed for a total of 14184 person years (mean=5.4years in all 
participants and 13.5 years in those still alive at 10 years after stroke). By 10 years after stroke 
1903 participants had died and 318 recurrent strokes were recoded. The corresponding 
figures at 15 years were 2066 deaths and 333 recurrences and 298 participants had not yet 
reached the 15 year follow-up point (see Figure S1 for numbers of deaths and recurrences 
other time points). Cumulative survival was 28·9% (95% CI 27·0-30·1) at 10 years and 20·6% 
(19·0-22·4) at 15 years (Figure 1) and at 10 years 65.3% (61.4-68.9) of survivors were 
recurrence free (54.4% (47.4-60.9) at 15 years) (table 1). 
The demographic characteristics of all participants at the time of stroke, and of those who 
survived 10 and 15 years are summarized in table 1. The median age at stroke onset was 73 
years (IQR 63 – 81) and 50·5% (95% CI 48·6-52·4) occurred in females. The majority of 
participants were of White ethnicity (74·5%, 72·8-76·1).  Fewer females than males survived 
to 10 and 15 years, by which time females constituted 41.2% (37·7-44·9) and 39·3% (33·5-45·4) 
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of survivors, respectively. Participants of Black ethnicity were also more likely to survive and 
represented almost one third of long term survivors (29·6%, 26·4-33·0) at 10 years and 15 
years (29·4%, 24·2-35·2). 
Table 1: Characteristics of SLSR participants recruited from 1995-2003 
 Whole cohort 10 years 15 years 
Number  alive and eligible for follow-up 2626 723 262 
Completed follow up, n(%)  409(56.7) 133(50.8) 
Number of deaths 
Cumulative survival, %(95% CI) 
 1903 
28·9% (27·0-30·1) 
2066 
20·6% (19·0-22·4) 
Number of recurrences 
Cumulative survival free of recurrence, 
%(95% CI) 
 318 
65.3% (61.4-68.9) 
333 
54.4%(47.4-60.9) 
Age  at stroke onset, median(IQR) 73(62·8-81·2) 62·1(52·0-69·7) 58·1(48·1-66·4) 
Sex, n(%(95% CI))    
   Male 1299(49·5(47·6-51·4)) 425(58·8(55·1-62·3)) 159(60·7(54·6-66·5)) 
   Female 1327(50·5(48·6-52·4)) 298(41·2(37·7-44·9)) 103(39·3(33·5-45·4)) 
Ethnicity, n(%(95% CI))    
   White 1956(74·5(72·8-76·1)) 438(60·6(57·0-64·1)) 163(62·2(56·1-67·9)) 
   Black 473(18·0(16·6-19·5)) 214(29·6(26·4-33·0)) 77(29·4(24·2-35·2)) 
   Other 197(7·5(6·6-8·6)) 71(9·8(7·9-12·2)) 22(8·4(5·6-12·5)) 
Stroke subtype, n(%(95% CI))    
   Ischaemic 1904(72·5(70·8-74·2)) 541(74·8(71··5-77·9)) 189(72·1(66·4-77·3)) 
   PICH 359(13·7(12·4-15·0)) 87(12·0()9·9-14·6) 34(13·0(9·4-17·6)) 
   SAH 157(6·0(5·1-7·0)) 72(10·0(8·0-12·4)) 32(12·2(8·7-16·8)) 
   Unclassified/Unknown 206(7·8(6·9-8·9)) 23(3·2(2·1-4·7)) 7(2·7(1·3-5·5)) 
The health status of stroke survivors was broadly similar at 10 and 15 years: the majority (10 
years: 85·1%, 15 years: 86·8%) of participants were living at home and most had some 
limitation in activities of activities of daily living, with a prevalence of mild-severe disability of 
67·0% (62·7-71·4) at 10 years and 63·2% (54·6-71·0) at 15 years (table 2)..  
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Table 2: Prevalence of outcomes at 10 and 15 years after stroke 
 10 year survivors, n(% (95% CI)) 15 year survivors, n(% (95% CI))) 
Living conditions   
   Private household alone/with others 372(85·1(81·5-88·2)) 125(86·8(80·1-91·5)) 
   Nursing home 26(6·0(4·1-8·6)) 0 
   Institution (long term hospital care) 32(7·3(5·2-10·2)) 18(12·5(8·0-19·1)) 
   Other/Unknown 7(1·6(0·7-3·3)) 1(0·69(0·7-3·3)) 
Barthel Index   
   Independent 135(33·0(28·6-37·3)) 49(36·8(29·0-45·4)) 
   Mild disability 165(40·3(35·7-45·2)) 45(33·8(26·2-42·4)) 
   Moderate disability 50(12·2(9·4-15·8)) 19(14·3(9·2-21·4)) 
   Severe disability 59(14·4(11·3-18·2)) 20(15·0(9·9-22·3)) 
Frenchay Activities index    
   Active 66(17·0(13·6-21·1)) 23(18·3(12·4-26·1)) 
   Moderately active 130(33·5(29·0-38·4)) 48(38·1(29·9-47·0)) 
   Inactive 192(49·5(44·5-54·5) 55(43·7(35·2-52·5)) 
HAD’s – Depression   
   Not depressed 244(64·4(59·4-69·1)) 78(60·9(52·1-69·1)) 
   Depressed 135(35·6(30·9-40·6)) 50(39·1(30·9-47·9)) 
HAD’s – Anxiety   
   Not Anxious 260(68·6(63·7-73·1)) 82(65·1(56·2-73·0)) 
   Anxious 119(31·4(26·9-36·3)) 44(34·9(27·0-43·8)) 
Cognitive state   
   Cognitively Intact 172(72·0(65·9-77·3)) 42(70·0(56·9-80·5)) 
   Cognitively impaired 67(28·0(22·7-34·1)) 18(30·0(19·5-43·1)) 
Quality of Life, mean(95% CI)   
   SF12 physical summary score 34·7(33·6-35·8) 35·3(33·4-37·2) 
   SF12 mental summary score 46·3(45·247·4) 44·1(42·2-46·2) 
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Fewer than one in five survivors were active (as measured by the Frenchay Activity Index) in 
their daily lives at both 10 and 15 years, and psychological impairments were identified in 
approximately one third of survivors, with 39·1% (30·9-47·9) screening positively for 
depression, 34·9% (27·0-43·8) for anxiety and 30·0% (19·5-43·1) for cognitive impairment at 15 
years. Stroke survivors reported poorer physical than mental HRQOL, with 15 year mean SF12 
physical and mental component summary scores of 35·3 and 44·1 respectively. 
The trends in the prevalence of functional, cognitive and psychological outcomes of stroke 
survivors alive at 10 years in the following five years are summarised in Figure 2. In this group 
the prevalence of functional, cognitive and psychological impairments was relatively stable 
up to 15 years. On average, between 10 and 15 years after stroke, 25% of survivors were 
moderately-severely disabled, 21% were inactive, 22% had cognitive impairments, 32% were 
anxious and 38% depressed. 
Outcomes after 10 years were associated with the level of disability survivors had 10 years 
after stroke (Figure 3).  
 When looking at 10 year survivors, who were independent in activities of daily living at 10 
years after stroke, 42·3% (27·1-57·5) remained so at 15 years. In those with a mild disability at 
10 years, over half (53·1%, 35·1-71·2) were either independent or had mild disability by 15 
years. Survival outcomes in patients with moderate-severe disability at 10 years were poor, 
with a five year mortality rate of death of 67·2% (55·5-76·0).  Outcomes stratified by disability 
level at three months after stroke were also estimated and results provided in supplementary 
Figure S2.  
 
The health status of patients who had survived to 15 years are summarized in Figure 4. The 
prevalence of moderate to severe disability increased over time and one in ten patients had 
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lived with moderate-severe disability since the stroke. A gradual increase in the prevalence 
of inactivity, depression and cognitive impairment was also observed, while the prevalence 
of anxiety remained stable at around 31%.  
DISCUSSION 
In this population based cohort of people with first ever stroke, we found that one in five lived 
to at least 15 years after stroke and poor outcomes were common in these long term 
survivors, at a prevalence similar to that observed in the short term after stroke. Within each 
of the domains assessed around one third had poor outcome at any given time. If these 
figures are representative of stroke outcomes in other countries, this implies that 
approximately 3.4 million of those having stroke each year globally will be alive 15 or more 
years after stroke. It is not certain whether long term survival and outcomes will be similar in 
other settings, particularly countries with less advanced healthcare systems, but nonetheless 
these findings help to quantify what projections from the Global Burden of Disease study 
[1]will mean in terms of the future burden of stroke on individuals, health systems and society 
as more patients survive stroke to experience stroke as a long term condition. Finally, they 
also highlight the need for more research and health service improvement focused on 
preventing and managing the long term consequences of stroke.  
Previous studies of stroke outcomes have been limited to relatively short follow up durations, 
with only a small number of studies reporting outcomes more than five years after stroke.[4 
7-15] The largest previous study of long term stroke outcomes was a survey of stroke patients 
admitted to hospital with stroke to Finland in the 1970s, of whom 19% were alive 14 years 
after stroke, a similar proportion to the current study.[13] Of these, approximately 30% self-
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reported severe disability and 40% minor disability, and psychological symptoms were 
common, with over half of responders reporting that they had low mood or depression.  
A similar prevalence of disability was observed at 10 years in a cohort of 45 stroke survivors 
in population based register from Australia, in whom the cumulative risk of disability was 44% 
at 10 years.[12] Survival and quality of life were reported at 21 years in 50 patients recruited 
in a population based register in Auckland, New Zealand.[10] Quality of life was considered 
acceptable in the majority of respondents and 19% required help with ADL – of these most (8 
of 9) considered functional impairments to be attributable to the stroke. The longest follow 
up of stroke outcomes reported to date was carried out as part of the Framingham cohort 
study, which described outcomes in 10 people who had lived at least 20 years after stroke.[11] 
Outcomes in this small group were generally good; most (8 of 10) were independent in ADL 
and able to drive a car and only one (11%) reported depression or cognitive impairment. 
However, all of these long term cohort studies are limited by small numbers and are now 
quite historic, and may not reflect more contemporary stroke outcomes or treatments (such 
as stroke unit based care or thrombolysis).  
The SLSR has also previously reported outcomes up to ten years after stroke.[9] This found 
that between 20-30% of stroke patients had a range of poor outcomes up to 10 years after 
stroke, providing evidence that stroke is associated with long term health outcomes. We have 
extended this previous study in several ways: firstly we have provided a further five years of 
long term follow up demonstrating a similar pattern of health outcomes and  providing 
uniquely detailed data on outcomes in very long term stroke survivors. Secondly we have used 
analytic approaches and data visualizations that focus on cumulative outcomes, better aiding 
in providing patient level prognostic estimates and in describing outcomes in incident stroke 
patients. For example, the estimates from this study could be used in sharing information 
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about prognosis with stroke patients and their families, and be used in planning health care 
services for long term stroke survivors. Equivalent long term outcomes data for other long 
term conditions is generally lacking and largely limited to survival only; these data therefore 
provide a relatively unique insight into the long term outlook across a broad array of health 
outcomes for patients with cardiovascular long term conditions. 
One of the challenges in interpreting these data is in ascertaining to what extent the observed 
outcomes are due to stroke itself versus the effect of accumulating multimorbidity or 
advancing age.  Multimorbidity in stroke patients [30] and in general populations [31] is 
common and the health outcomes of the patients in this study will be the result of both 
accumulating multimorbidity and of the stroke itself. Nonetheless, these data show that  
although there was some accumulation of poor health outcomes in survivors over time, many 
of the patients with physical disability at 15 years had lived with disability since their stroke; 
stroke can directly impact long term health and is not just a risk factor or marker for 
subsequent health decline. The data from these long term survivors is also evidence that 
some people (generally younger) with stroke may survive for many years after stroke despite 
having severe disability and that poor health outcomes do not decline in prevalence with 
time. This highlights the need to focus research and health service improvement not just on 
acute stroke care but also on the problems faced by long term stroke survivors.  
 
The strengths of this study include the use of a population based register specifically designed 
to identify all strokes occurring in the defined cohort, reducing the risk of selection bias. The 
study also used longitudinal follow up at multiple time points, enabling the long term 
trajectory of stroke outcomes to be described and reducing the impact of missing data. Data 
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collection was standardized through the use of validated instruments and through data 
collection by trained fieldworkers, helping to main accuracy and consistency.  
 
The main limitation of the study is missing data for patients who were lost to follow up or left 
the area – maintaining contact in very long term cohort studies is challenging and multiple 
methods were used for tracing and to contact patients who moved out of area. While this 
study reports on data from one of the largest cohorts of stroke survivors to date, due to high 
mortality rates up to 10 years after stroke, only a quarter of the initial cohort were eligible to 
be included. Incomplete follow-up data reduced the number further and has the potential to 
introduce bias and reduce precision of estimates. However we found that the only major 
variable associated with missing data was age 10 years after stroke. We have carried out 
simulation studies which found that the results are robust to the observed pattern of missing 
data and not meaningfully improved by multiple imputation (Crichton - PhD Thesis currently 
in submission). The setting of the study in an inner city area of London also means that the 
source population of the study area is unlikely to be representative of the UK population as a 
whole; in particular the proportion of the population who are from non-white ethnic groups 
is around 30% point higher  than that for the UK as a whole. We observed a greater proportion 
of long term survivors to be of black ethnicity than among the whole cohort. It has previously 
been shown that in the SLSR the average age at onset among the black population is 10 years 
lower in those of white ethnicity [18] and so the proportion of stroke survivors surviving 
beyond 10 years may be lower in the general population. This study also lacked a control 
group of patients without stroke, which would have strengthened the study and enabled 
comparisons of health status with people without stroke. This is a fundamental aspect of the 
design of the cohort study that cannot be changed retrospectively, but we are exploring the 
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use of data linkage that will enable us in the future to sample a control group from the local 
population using electronic health records. Other limitations are that the assessment of 
mental health and cognitive outcomes made use of screening instruments rather than full 
neuropsychological or clinical assessments and that the data do not include measurements 
of some outcomes that stroke survivors identify as being important, such as fatigue.[32] Other 
factors that were collected, such as recurrent stroke, are likely to impact on long term 
outcomes. However, the aim of this study was to describe outcomes for a population and 
describing the impact of factors on outcomes was outside the scope of this work. Similarly, 
the dataset did not include some potentially relevant variables that contribute to health 
status, such as marital status and level of family support. In practice more comprehensive 
assessments would have been logistically difficult to administer given the size of the cohort 
and long duration of the SLSR, and the data remain one of the most detailed descriptions of 
the long term outcomes of a cardiovascular long term condition ever collected.  
CONCLUSION 
This study provides some of the most detailed, year-on-year estimates of the very long term 
outcomes of stroke, describing not just survival but also outcomes across a broad range of 
physical, quality of life and mental health domains. As well as being useful prognostically, 
these data help to quantify the impact on populations of the epidemiological shift of stroke 
towards a long term condition and highlight the need to focus not just on reducing stroke 
mortality, but on preventing and managing the long term consequences of stroke.  
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FIGURE LEGENDS 
 
Figure 1: Kaplan Meier survival estimates with 95% confidence interval.  
 
Figure 2: Functional, cognitive and psychological outcomes between 10 and 15 years after 
stroke 
 
Figure 3: Barthel index between 10 and 15 years after stroke stratified by functional status at 
10 years after stroke 
 
Figure 4: Functional, cognitive and psychological outcomes of 15 year survivors 
 
Figure S1: Flow diagram showing status of SLSR participants up to 15 years after stroke 
 
Figure S2: Barthel index up to 15 years after stroke stratified by functional status at 3 months 
after stroke 
 
 
 
